A robust quality system is central to patient safety, both in production and in the conduct of clinical trials.
InnoMedica manufactures in compliance with Good Manufacturing Practice (GMP) guidelines. The quality management system is certified by Swissmedic and forms the foundation for the safe and reproducible production of liposomal medicines. GMP quality control begins prior to production and extends throughout the entire process, including logistics from the supplier to the clinic.
With the company’s role as a clinical trial sponsor, the quality system was gradually expanded to include the requirements of Good Clinical Practice (GCP). These guidelines ensure patient safety during clinical trials. By closely integrating GMP and GCP, InnoMedica has created a comprehensive quality framework that enables independent execution of clinical studies and strengthens the overall high standards across the entire development and manufacturing chain.
